Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case Report

Toxoplasmosis is caused by infection with the obligate intracellular parasite Toxoplasma gondii. Toxoplasmosis is generally a late complication of HIV infection and usually occurs in patients with CD4 + T-cell counts below 200/μl. Co-trimoxazole (trimethoprim plus sulfamethoxazole) is the most commo...

Full description

Bibliographic Details
Main Authors: Deepak Madi, Basavaprabhu Achappa, Satish Rao, John T. Ramapuram, Soundarya Mahalingam
Format: Article
Language:English
Published: Oman Medical Specialty Board 2012-09-01
Series:Oman Medical Journal
Subjects:
Online Access:http://www.omjournal.org/fultext_PDF.aspx?DetailsID=292&type=fultext
_version_ 1819037309142564864
author Deepak Madi
Basavaprabhu Achappa
Satish Rao
John T. Ramapuram
Soundarya Mahalingam
author_facet Deepak Madi
Basavaprabhu Achappa
Satish Rao
John T. Ramapuram
Soundarya Mahalingam
author_sort Deepak Madi
collection DOAJ
description Toxoplasmosis is caused by infection with the obligate intracellular parasite Toxoplasma gondii. Toxoplasmosis is generally a late complication of HIV infection and usually occurs in patients with CD4 + T-cell counts below 200/μl. Co-trimoxazole (trimethoprim plus sulfamethoxazole) is the most common drug used in India for the treatment of AIDS-associated cerebral toxoplasmosis. Other alternative drugs used for the treatment of cerebral toxoplasmosis are clindamycin plus pyrimethamine and clarithromycin with pyrimethamine.A 30-year-old male known case of retroviral disease presented to Kasturba Medical College, India, with complaints of fever, headache and vomiting. Computed tomography scan of his brain showed irregular ring enhancing lesion in the right basal ganglia. Toxoplasma serology revealed raised IgG antibody levels. Based on the CT features and serology, diagnosis of cerebral toxoplasmosis was made. He was treated with clindamycin alone as he had historyof sulfonamide allergy. The patient was symptomatically better after 48 hours. After 21 days, repeat CT of brain was done which was normal. The patient showed good clinical improvement within 48 hours and the lesion resolved completely within 3 weeks. The authors recommend using clindamycin without pyrimethamine in resource poor settings and in patients who do not tolerate sulfa drugs.
first_indexed 2024-12-21T08:19:22Z
format Article
id doaj.art-b3f26ffa290c40fc8ea72a7e81cb1390
institution Directory Open Access Journal
issn 1999-768X
2070-5204
language English
last_indexed 2024-12-21T08:19:22Z
publishDate 2012-09-01
publisher Oman Medical Specialty Board
record_format Article
series Oman Medical Journal
spelling doaj.art-b3f26ffa290c40fc8ea72a7e81cb13902022-12-21T19:10:28ZengOman Medical Specialty BoardOman Medical Journal1999-768X2070-52042012-09-01275411412Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case ReportDeepak MadiBasavaprabhu AchappaSatish RaoJohn T. RamapuramSoundarya MahalingamToxoplasmosis is caused by infection with the obligate intracellular parasite Toxoplasma gondii. Toxoplasmosis is generally a late complication of HIV infection and usually occurs in patients with CD4 + T-cell counts below 200/μl. Co-trimoxazole (trimethoprim plus sulfamethoxazole) is the most common drug used in India for the treatment of AIDS-associated cerebral toxoplasmosis. Other alternative drugs used for the treatment of cerebral toxoplasmosis are clindamycin plus pyrimethamine and clarithromycin with pyrimethamine.A 30-year-old male known case of retroviral disease presented to Kasturba Medical College, India, with complaints of fever, headache and vomiting. Computed tomography scan of his brain showed irregular ring enhancing lesion in the right basal ganglia. Toxoplasma serology revealed raised IgG antibody levels. Based on the CT features and serology, diagnosis of cerebral toxoplasmosis was made. He was treated with clindamycin alone as he had historyof sulfonamide allergy. The patient was symptomatically better after 48 hours. After 21 days, repeat CT of brain was done which was normal. The patient showed good clinical improvement within 48 hours and the lesion resolved completely within 3 weeks. The authors recommend using clindamycin without pyrimethamine in resource poor settings and in patients who do not tolerate sulfa drugs.http://www.omjournal.org/fultext_PDF.aspx?DetailsID=292&type=fultextCerebral toxoplasmosisClindamycinHIV/AIDS.
spellingShingle Deepak Madi
Basavaprabhu Achappa
Satish Rao
John T. Ramapuram
Soundarya Mahalingam
Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case Report
Oman Medical Journal
Cerebral toxoplasmosis
Clindamycin
HIV/AIDS.
title Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case Report
title_full Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case Report
title_fullStr Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case Report
title_full_unstemmed Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case Report
title_short Successful Treatment of Cerebral Toxoplasmosis with Clindamycin: A Case Report
title_sort successful treatment of cerebral toxoplasmosis with clindamycin a case report
topic Cerebral toxoplasmosis
Clindamycin
HIV/AIDS.
url http://www.omjournal.org/fultext_PDF.aspx?DetailsID=292&type=fultext
work_keys_str_mv AT deepakmadi successfultreatmentofcerebraltoxoplasmosiswithclindamycinacasereport
AT basavaprabhuachappa successfultreatmentofcerebraltoxoplasmosiswithclindamycinacasereport
AT satishrao successfultreatmentofcerebraltoxoplasmosiswithclindamycinacasereport
AT johntramapuram successfultreatmentofcerebraltoxoplasmosiswithclindamycinacasereport
AT soundaryamahalingam successfultreatmentofcerebraltoxoplasmosiswithclindamycinacasereport